前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201902257293583343
整理番号：19A0924593
マルチパラメトリックフローサイトメトリー前移植により決定された最小残存疾患状態は,全ての未操作ハプロタイプ同種移植片を受けた患者の転帰を予測する【JST・京大機械翻訳】
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts
Zhao Xiao-Su
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Zhao Xiao-Su
(Peking-Tsinghua Center for Life Sciences, Beijing, China)
,
Liu Yan-Rong
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Xu Lan-Ping
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Wang Yu
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Wang Yu
(Peking-Tsinghua Center for Life Sciences, Beijing, China)
,
Zhang Xiao-Hui
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Zhang Xiao-Hui
(Peking-Tsinghua Center for Life Sciences, Beijing, China)
,
Chen Huan
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Chen Yu-Hong
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Han Wei
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Sun Yu-Qian
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Yan Chen-Hua
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Mo Xiao-Dong
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Wang Ya-Zhe
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Fan Qiao-Zhen
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Wang Xin-Yu
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Liu Kai-Yan
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Huang Xiao-Jun
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Huang Xiao-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Chang Ying-Jun
(Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital & Peking University Institute of Hematology, Beijing, China)
,
Chang Ying-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
資料名：
American Journal of Hematology
(American Journal of Hematology)
巻： 94 号： 5 ページ： 512-521 発行年： 2019年
JST資料番号： E0721B ISSN： 0361-8609 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： アメリカ合衆国 (USA) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。